Anal Cancer Clinical Trials

164 clinical trials for Anal Cancer across international registries, including 33 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer — RECRUITING · PHASE2
• Distance-Based Exercise to Preserve Function and Prevent Disability — RECRUITING · NA
• Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer — RECRUITING · PHASE2
• DESTINY-PANTUMOUR04 — RECRUITING
• Integrated Cancer Repository for Cancer Research — RECRUITING
• E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers — RECRUITING · PHASE2
• E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers — RECRUITING · PHASE1
• EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. — RECRUITING · NA
• Self-sampling to Optimize Anal Lesion Outcomes — RECRUITING · NA
• Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis — RECRUITING · NA
• Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy — RECRUITING · NA
• Detecting HPV DNA in Anal and Cervical Cancers — RECRUITING
• Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes — RECRUITING · NA
• HPV Genotype Attribution and Disease Burden of Anal Cancer in China — RECRUITING
• Beyond Survival: Addressing Gynecological and Sexual Health in Women After Radiotherapy for Anal Cancer — RECRUITING
• Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial — RECRUITING · NA
• Deciphering Mechanisms Underlying Cancer Immunogenicity — RECRUITING · NA
• Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA — RECRUITING · PHASE3
• Stigma and Psychological profilE in REctal-anal caNcer pAtients — RECRUITING
• Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. — RECRUITING · NA
• A Study Regarding Tissue Response During and After Treatment for Anal Cancer — RECRUITING
• Host Genome Methylation: a Screening Tool in Anal Cancer Detection — RECRUITING · NA
• Multidimensional Examination of Patients with Colorectal and Anal Cancer — RECRUITING
• NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal Cancer — RECRUITING · NA
• SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas — RECRUITING · PHASE1
• Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens — RECRUITING
• HRYZ-T101 Injection for HPV18 Positive Solid Tumor — RECRUITING · PHASE1
• ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer — RECRUITING
• Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer — RECRUITING
• A PROSPECTIVE PHASE II STUDY OF INGUINAL NODE SPARING RADIOTHERAPY FOR PATIENTS WITH EARLY STAGE ANAL CANCER (INSPIRE) — RECRUITING · PHASE2
• Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy (DACG 5) — RECRUITING · PHASE2
• Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE) — RECRUITING
• A RANDOMIZED PHASE II STUDY OF NIVOLUMAB AFTER COMBINED MODALITY THERAPY (CMT) IN HIGH-RISK ANAL CANCER — RECRUITING · PHASE2
• Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC — COMPLETED
• Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group — ACTIVE_NOT_RECRUITING · PHASE2
• Assessment of Patients' Quality of Sexual Life After Anal Cancer Treatment — ACTIVE_NOT_RECRUITING
• Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women — ACTIVE_NOT_RECRUITING
• Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers — NOT_YET_RECRUITING
• ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION STRATEGIES — ACTIVE_NOT_RECRUITING
• Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies — COMPLETED · PHASE1
• COQ10 and Vitamin E for Off-Target Radiation Toxicity — NOT_YET_RECRUITING · PHASE1
• Individual Following in Anal Cancer With PET/CT — COMPLETED
• A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers — ACTIVE_NOT_RECRUITING · PHASE1
• Blood Biomarkers Based Screening for HPV-driven OPC — NOT_YET_RECRUITING · NA
• HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers — ACTIVE_NOT_RECRUITING · PHASE1
• Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With HPV-positive Pelvic Cancer: a Descriptive Longitudinal Study — NOT_YET_RECRUITING · NA
• Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors — TERMINATED · PHASE1
• A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors — TERMINATED · PHASE2
• A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers — ACTIVE_NOT_RECRUITING · PHASE1

Refine this search